Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Search content at University of Arizona
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Lessons learnt from broad-spectrum coronavirus antiviral drug discovery
Andrew A. Bolinger
, Jun Li
, Xuping Xie
,
Hongmin Li
, Jia Zhou
Pharmacology and Toxicology
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lessons learnt from broad-spectrum coronavirus antiviral drug discovery'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Coronavirus
100%
Lessons Learned
100%
Antiviral Drug Discovery
100%
Highly Pathogenic Coronavirus
75%
Public Health System
50%
Broad-spectrum Antivirals
50%
COVID-19 Pandemic
50%
Potential Impact
25%
Clinical Manifestations
25%
Structural Proteins
25%
Viral Proteins
25%
Human Population
25%
Protein Drug
25%
High Morbidity
25%
High Mortality
25%
Resilience
25%
Vulnerability
25%
Area Cover
25%
Expert Opinion
25%
Distress Disorders
25%
Combinational Approaches
25%
Targeted Treatment
25%
Severe Acute Respiratory Syndrome
25%
Drug Repurposing
25%
Repurposing Approaches
25%
Efficient Development
25%
Severe Acute Respiratory syndrome-CoV-2
25%
Novel Coronavirus
25%
Middle East Respiratory Syndrome
25%
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
100%
Antivirus Agent
100%
Coronavirinae
100%
Antiviral Drug
100%
Pandemic
66%
Severe Acute Respiratory Syndrome
66%
Adult Respiratory Distress Syndrome
33%
Structural Protein
33%
Viral Protein
33%
Drug Repositioning
33%
Distress Syndrome
33%
Middle East Respiratory Syndrome
33%
Medicine and Dentistry
Antivirus Agent
100%
Coronavirinae
100%
Coronavirus
100%
Antiviral Drug
42%
Health System
28%
Public Health
28%
COVID-19
28%
Severe Acute Respiratory Syndrome
28%
Acute Respiratory Distress Syndrome
14%
Targeted Therapy
14%
Structural Protein
14%
Distress Syndrome
14%
Viral Protein
14%
Drug Repositioning
14%
Middle East Respiratory Syndrome
14%